Page last updated: 2024-08-21

benzoxazoles and cardiovascular agents

benzoxazoles has been researched along with cardiovascular agents in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (42.86)24.3611
2020's3 (42.86)2.80

Authors

AuthorsStudies
CAIN, CK; PLAMPIN, JN1
Ao, Z; Bradley, BT; Daniels, E; Douglas, SA; Gatto, GJ; Goodman, KB; Goserud, MT; Harpel, MR; Johns, DG; Kearse, MG; Morales, CR; Zhou, M1
Hayward, LF; Hernandez, ME; Martin, EJ1
Autore, C; Canepa, M; Cappelli, F; Milandri, A; Mussinelli, R; Musumeci, B; Perfetto, F; Perlini, S; Rapezzi, C; Tini, G1
Butler, J; Khan, MS; Vaduganathan, M1
Almeida, AR; Azevedo, O; Bento, D; Correia, E; Cruz, I; Lopes, LR; Lourenço, C; Marques, N1
Benbrahim, M; Hughes, D; Norman, K; Sanchorawala, V; Siddiqi, OK1

Reviews

2 review(s) available for benzoxazoles and cardiovascular agents

ArticleYear
Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations.
    Journal of the American Heart Association, 2020, 10-20, Volume: 9, Issue:19

    Topics: Amyloid Neuropathies, Familial; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Genetic Therapy; Humans

2020
A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis.
    Journal of cardiovascular pharmacology, 2021, 05-01, Volume: 77, Issue:5

    Topics: Amyloid Neuropathies, Familial; Animals; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Diflunisal; Genetic Predisposition to Disease; Humans; Mutation; Oligonucleotides; Phenotype; Prealbumin; RNA, Small Interfering; Treatment Outcome

2021

Other Studies

5 other study(ies) available for benzoxazoles and cardiovascular agents

ArticleYear
SYNTHESIS OF METABOLIC PRODUCTS OF BENZOXAZOLES.
    Journal of medicinal chemistry, 1963, Volume: 6

    Topics: Benzoxazoles; Cardiovascular Agents; Chemistry, Pharmaceutical; Metabolism; Mice; Muscle Relaxants, Central; Oxazoles; Pharmacology; Research; Zoxazolamine

1963
NADPH oxidase-dependent and -independent mechanisms of reported inhibitors of reactive oxygen generation.
    Journal of enzyme inhibition and medicinal chemistry, 2013, Volume: 28, Issue:1

    Topics: Base Sequence; Benzoxazoles; Cardiovascular Agents; Cells, Cultured; Enzyme Inhibitors; Humans; Membrane Glycoproteins; Molecular Sequence Data; NADPH Oxidase 2; NADPH Oxidases; Neutrophils; Perhexiline; Protein Kinase C; Protein Kinase C beta; Reactive Oxygen Species; Suramin; Triazoles

2013
Blockade of orexin receptors attenuates the cardiovascular response to air-jet stress in spontaneously hypertensive rats.
    Autonomic neuroscience : basic & clinical, 2016, Volume: 201

    Topics: Acetamides; Air; Animals; Benzoxazoles; Blood Pressure; Brain; Brain-Derived Neurotrophic Factor; Cardiovascular Agents; Dose-Response Relationship, Drug; Heart Rate; Isoquinolines; Male; Naphthyridines; Orexin Receptor Antagonists; Orexin Receptors; Physical Stimulation; Random Allocation; Rats, Inbred SHR; Rats, Wistar; RNA, Messenger; Species Specificity; Stress, Psychological; Urea

2016
Real-world versus trial patients with transthyretin amyloid cardiomyopathy.
    European journal of heart failure, 2019, Volume: 21, Issue:11

    Topics: Aged; Aged, 80 and over; Amyloid Neuropathies, Familial; Angiotensin-Converting Enzyme Inhibitors; Benzoxazoles; Cardiomyopathies; Cardiovascular Agents; Clinical Trials as Topic; Diuretics; Female; Humans; Male; Rare Diseases

2019
Orphan Drug Development in Cardiovascular Medicine.
    Circulation. Cardiovascular quality and outcomes, 2020, Volume: 13, Issue:7

    Topics: Benzoxazoles; Cardiovascular Agents; Cardiovascular Diseases; Cost-Benefit Analysis; Drug Approval; Drug Costs; Drug Development; Humans; Orphan Drug Production; Treatment Outcome

2020